Organicell Regenerative Medicine Inc (PK:BPSR)

May 27, 2020 07:00 am ET
Organicell Reports Positive Results from Compassionate Use of Organicell Flow in Severely Ill COVID-19 Patients
Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today a health update for two critically ill COVID-19 patients who were treated at...
May 19, 2020 07:00 am ET
FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19
Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that on May 11, 2020, the U.S. Food and Drug Administration (FDA) authorized two...
May 05, 2020 08:00 am ET
Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19
Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration (FDA) has approved the...
Jan 21, 2020 09:54 am ET
Organicell Regenerative Medicine Inc. Provides Update On Operations and Financial Reporting Status
Organicell Regenerative Medicine Inc. (OTCPK:BPSR) (the “Company”) is pleased to provide shareholders and the investment community with an update on operations since its filing on November 1, 2018 of the Company’s Annual Report on Form filing of...
Feb 25, 2019 12:00 pm ET
Organicell Welcomes Dr. George C. Shapiro To The Medical Advisory Board
BOCA RATON, Fla., Feb. 25, 2019 /PRNewswire/ -- Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (OTC: BPSR), today announced the appointment of George C. Shapiro, M.D. F.A.C.C. to its medical advisory board. In addition to serving on the Company's Advisory Board, Dr. Shapiro is assembling the medical advisory board for Organicell....
Jan 30, 2019 12:35 pm ET
Organicell Regenerative Medicine Inc., Biotech Products Services and Research, Inc. Update for Shareholders
BOCA RATON, Fla., Jan. 30, 2019 /PRNewswire/ -- Biotech Products Services and Research, Inc. operating as Organicell Regenerative Medicine Inc. (OTC: BPSR), today is providing its shareholders with an update on the Company's progress....